Skip to main content
. 2020 Feb 18;11(2):125. doi: 10.1038/s41419-020-2324-4

Fig. 7. SESN2-inhibited PERK-CHOP pathway to protect DC2.4 cells from ERS-related cell apoptosis.

Fig. 7

a Various dosages of GSK2656157 was pretreated cells for 1 h, then stimulation with 100 ng/ml HMGB1 for 48 h. ATF4 and SESN2 in DC2.4 cells were determined by Western blotting. b, c After induction with siRNA or LV-RNA for 72 h, DC2.4 cells were treated with 100 ng/ml HMGB1 for 48 h, then SESN2 as well as ERS apoptotic-related protein CHOP were examined by Western blotting. β-actin served as the internal standard. Data were presented as the mean ± SD, n = 3 per group. Statistical significance: *P < 0.05 versus the scramble group; #P < 0.05 versus the scramble group treated with HMGB1; &P < 0.05 versus the scramble group treated with HMGB1 and GSK2656157.